期刊文献+

人成釉细胞瘤中pRb和E2F-1表达与端粒酶活性的关系 被引量:7

Expression of pRb and E2F-1 and telomerase activity in ameloblastoma
原文传递
导出
摘要 目的 研究 pRb、E2F 1和细胞周期素E(cyclinE)在人成釉细胞瘤 (ameloblastoma,AB)中的表达及其与端粒酶 (hTERT)的关系 ,探讨其临床生物学意义。方法 用原位杂交和免疫组化SP法分别检测了AB中 pRb、E2F 1、cyclinE及hTERTmRNA的表达。结果 pRb在AB细胞核中阳性率为2 0 4 % ( 11/ 5 4 )。E2F 1mRNA阳性率为 92 6 % ( 5 0 / 5 4 )。cyclinEmRNA阳性率为 6 6 7% ( 36 / 5 4 )。hTERTmRNA阳性率为 94 4 % ( 5 1/ 5 4 )。伴随AB的复发与恶变 ,hTERT、E2F 1、cyclinE的表达逐渐增高 ,pRb表达丢失。hTERT与E2F 1、cyclinEmRNA之间经Spearman相关分析 ,rs 均为 1 0 0 0 ,P =0 0 0 0 1,呈高度正相关。结论 pRb/E2F 1与AB细胞的增殖、去分化相关 ,端粒酶活性的释放激活与pRb的低表达及E2F 1的高表达可能相关 。 Objective To investigate the expression of pRb and E2F 1, and the association between their expression and the activity of telomerase (hTERT) or cyclin E in human ameloblastoma (AB), and to explore the clinical biological characteristics of AB. Methods The expressions of pRb, E2F 1 , cyclin E and hTERT mRNA in human AB were detected by in situ hybridization or immunohistochemistry (SP method). Results The positive expression ratio of pRb in the cell nucleus of AB was 20 4% (11/54). The positive ratio of E2F 1, cyclin E and hTERT mRNA was 92 6% (50/54), 66 7% (36/54) and 94 4% (51/54), respectively. With AB recurrence and malignant transformation , the expression of hTERT, E2F 1, cyclin E was up regulated. hTERT and cyclin E or E2F 1 mRNA had high positive relation (Spearsman′ r s =1 000, P =0 0001). Conclusions The regulatory pathway of Rb /E2F 1 is associated with the cell proliferation and indifferentiation of AB. The activity or release of telomerase may be related to the lower expression of Rb and higher expression of E2F 1, and is up regulated in G 1 late phase by cyclin E.
出处 《中华口腔医学杂志》 CAS CSCD 北大核心 2004年第5期406-409,共4页 Chinese Journal of Stomatology
基金 辽宁省自然科学基金 (2 0 0 3 2 0 5 7) 辽宁省教育厅基金(2 0 12 2 17) 沈阳市科委基金(2 0 0 13 8 7)资助项目
关键词 成釉细胞瘤 PRB E2F-1 端粒酶活性 细胞周期素E Ameloblastoma Transcription factors Telomerase Cyclin E
  • 相关文献

参考文献11

  • 1Nguyen DC, Crowe DL. Intact functional domains of the retinoblastoma gene product (pRb) are required for downregulation of telomerase activity. Biochim Biophys Acta, 1999, 1445: 207-215. 被引量:1
  • 2Hanahan D, Weinberg RA . The hallmarks of cancer. Cell, 2000, 100: 57-70. 被引量:1
  • 3Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev, 1998,12:2245-2262. 被引量:1
  • 4Sears RC, Nevins JR. Signaling networks that link cell proliferation and cell fate. J Biol Chem, 2002, 277: 11617-11620. 被引量:1
  • 5Landberg G, Nielsen NH, Nilsson P, et al. Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Res, 1997, 57: 549-554. 被引量:1
  • 6Crowe DL, Nguyen DC. Rb and E2F-1 regulate telomerase activity in human cancer cells. Biochim Biophys Acta, 2001, 1518: 1-6. 被引量:1
  • 7Sherr CJ. Cancer cell cycles. Science, 1996, 274: 1672-1677. 被引量:1
  • 8Yamasaki L, Jacks T, Bronson R, et al. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell, 1996, 85: 537-548. 被引量:1
  • 9Takakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res, 1999, 59: 被引量:1
  • 10钟鸣,岳阳丽,王洁,王兆元.人成釉细胞瘤中端粒酶活性与细胞周期素A的表达[J].中华口腔医学杂志,2003,38(4):257-260. 被引量:11

二级参考文献3

共引文献13

同被引文献54

引证文献7

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部